Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris

Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris
Stereotaxis unveils robotic EP tech

Stereotaxis, Inc. is set to present its newest advancements in robotic electrophysiology at the upcoming EHRA2026 conference in Paris.

The company aims to demonstrate cutting-edge technologies at their booth, inviting attendees to explore the transformative potential of robotic cardiology procedures. Stereotaxis, Inc.'s participation underscores their ongoing commitment to innovation within cardiac care and medical robotics.

The company previously promoted its RoboticEP platform as a solution to reduce radiation exposure for patients and doctors during procedures, according to a company statement. Stereotaxis has also offered an interactive online demonstration to showcase the platform’s capabilities. These initiatives coincide with Stereotaxis' efforts to expand the adoption of robotic technologies in cardiology.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.